Nighttime administration of antihypertensive medication: a review of chronotherapy in hypertension
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hypertension remains a global health concern because of suboptimal blood pressure control despite advancements in antihypertensive treatments. Chronotherapy, defined as evening or bedtime administration of medication based on biological rhythms, is emerging as a potential strategy to improve blood pressure control and treatment outcomes. Clinical trials have investigated the potential effects of nighttime administration of antihypertensive medication in the improvement of 24 hours blood pressure control and reduction of cardiovascular risk. Implementing chronotherapy in clinical practice could have significant implications in enhancing blood pressure control and improving clinical outcomes in patients with hypertension, particularly those with resistant hypertension. However, recent trials have reported contradictory results, causing confusion in real-world practice. Herein we review, analyze, and critique the current evidence and propose suggestions regarding the clinical application and future directions of chronotherapy.
Abstract
Hypertension remains a global health concern because of suboptimal blood pressure control despite advancements in antihypertensive treatments. Chronotherapy, defined as evening or bedtime administration of medication based on biological rhythms, is emerging as a potential strategy to improve blood pressure control and treatment outcomes. Clinical trials have investigated the potential effects of nighttime administration of antihypertensive medication in the improvement of 24 hours blood pressure control and reduction of cardiovascular risk. Implementing chronotherapy in clinical practice could have significant implications in enhancing blood pressure control and improving clinical outcomes in patients with hypertension, particularly those with resistant hypertension. However, recent trials have reported contradictory results, causing confusion in real-world practice. Herein we review, analyze, and critique the current evidence and propose suggestions regarding the clinical application and future directions of chronotherapy.
참고문헌 (64)
- Forouzanfar MH, "Global burden of hypertension and systolic blood pressure of at least 110 to 115mm Hg, 1990-2015", JAMA, 317, pp.165~182 (2017)
- NCD Risk Factor Collaboration(NCD-RisC), "Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants", Lancet, 398, pp.957~980 (2021)
- Kim HC, "Korea hypertension fact sheet 2020 : analysis of nationwide population-based data", Clin Hypertens, 27, pp.8~ (2021)
- Kim HC, "Epidemiology of cardiovascular disease and its risk factors in Korea", Glob Health Med, 3, pp.134~141 (2021)
- Hermida RC, "Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks", Hypertens Res, 39, pp.277~292 (2016)
- Sole MJ, "Diurnal physiology : core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure", J Appl Physiol(1985), 107, pp.1318~1327 (2009)
- El Jamal N, "The circadian biology of heart failure", Circ Res, 132, pp.223~237 (2023)
- Rabinovich-Nikitin I, "Circadian-Regulated cell death in cardiovascular diseases", Circulation, 139, pp.965~980 (2019)
- Collot M, "MemBright : A family of fluorescent membrane probes for advanced cellular imaging and neuroscience", Cell Chem Biol, 26, pp.600~614 (2019)
- Ayyar VS, "Circadian rhythms : influence on physiology, pharmacology, and therapeutic interventions", J Pharmacokinet Pharmacodyn, 48, pp.321~338 (2021)
- Portaluppi F, "Circadian rhythms and cardiovascular health", Sleep Med Rev, 16, pp.151~166 (2012)
- Costello HM, "Circadian rhythm, clock genes, and hypertension : recent advances in hypertension", Hypertension, 78, pp.1185~1196 (2021)
- Hermida RC, "Circadian variation of blood pressure : the basis for the chronotherapy of hypertension", Adv Drug Deliv Rev, 59, pp.904~922 (2007)
- Huikuri HV, "Reproducibility and circadian rhythm of heart rate variability in healthy subjects", Am J Cardiol, 65, pp.391~393 (1990)
- Yang G, "Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival", Sci Transl Med, 8, pp.324ra16~ (2016)
- Curtis AM, "Circadian variation of blood pressure and the vascular response to asynchronous stress", Proc Natl Acad Sci U S A, 104, pp.3450~3455 (2007)
- Wang N, "Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1", Cell Metab, 8, pp.482~491 (2008)
- Martino TA, "Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization", Hypertension, 49, pp.1104~1113 (2007)
- Young ME, "Intrinsic diurnal variations in cardiac metabolism and contractile function", Circ Res, 89, pp.1199~1208 (2001)
- Somers VK, "Sympathetic-nerve activity during sleep in normal subjects", N Engl J Med, 328, pp.303~307 (1993)
- Kawano Y, "Circadian variation of haemodynamics in patients with essential hypertension : comparison between early morning and evening", J Hypertens, 12, pp.1405~1412 (1994)
- Lakatua DJ, "Circadian characteristics of urinary epinephrine and norepinephrine from healthy young women in Japan and U. S. A", Chronobiol Int, 3, pp.189~195 (1986)
- Linsell CR, "Circadian rhythms of epinephrine and norepinephrine in man", J Clin Endocrinol Metab, 60, pp.1210~1215 (1985)
- Armbruster H, "Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol", Acta Endocrinol(Copenh), 80, pp.95~103 (1975)
- Cugini P, "The circadian rhythmicity of serum angiotensin converting enzyme : its phasic relation with the circadian cycle of plasma renin and aldosterone", Chronobiologia, 15, pp.229~231 (1988)
- White WB, "Importance of blood pressure control over a 24-hour period", J Manag Care Pharm, 13(8 Suppl B), pp.34~39 (2007)
- Kario K, "Preface : EDITORIAL COMMENT"Perfect 24-hr Blood Pressure Control"from morning to nocturnal hypertension : up-to-date 2015", Curr Hypertens Rev, 11, pp.2~6 (2015)
- Fagard RH, "Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension", Hypertension, 51, pp.55~61 (2008)
- Parati G, "European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring", J Hypertens, 32, pp.1359~1366 (2014)
- Hermida RC, "Influence of circadian time of hypertension treatment on cardiovascular risk : results of the MAPEC study", Chronobiol Int, 27, pp.1629~1651 (2010)
- Sherwood A, "Nighttime blood pressure dipping : the role of the sympathetic nervous system", Am J Hypertens, 15(2 Pt 1), pp.111~118 (2002)
- Lévi F, "Implications of circadian clocks for the rhythmic delivery of cancer therapeutics", Adv Drug Deliv Rev, 59, pp.1015~1035 (2007)
- Wirz-Justice A, "Chronotherapeutics(light and wake therapy)in affective disorders", Psychol Med, 35, pp.939~944 (2005)
- Fagard RH, "Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension", J Hum Hypertens, 23, pp.645~653 (2009)
- Palatini P, "Effect of evening versus morning benazepril on 24-hour blood pressure : a comparative study with continuous intraarterial monitoring", Int J Clin Pharmacol Ther Toxicol, 31, pp.295~300 (1993)
- Middeke M, "Chronopharmacology of captopril plus hydrochlorothiazide in hypertension : morning versus evening dosing", Chronobiol Int, 8, pp.506~510 (1991)
- Witte K, "Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration", Clin Pharmacol Ther, 54, pp.177~186 (1993)
- Sunaga K, "Chronopharmacology of enalapril in hypertensive patients", Eur J Clin Pharmacol, 48, pp.441~445 (1995)
- Pechère-Bertschi A, "Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients", J Hypertens, 16, pp.385~393 (1998)
- Kohno I, "Effect of imidapril in dipper and nondipper hypertensive patients : comparison between morning and evening administration", Chronobiol Int, 17, pp.209~219 (2000)
- Macchiarulo C, "Management of antihypertensive treatment with Lisinopril : a chronotherapeutic approach", Eur Rev Med Pharmacol Sci, 3, pp.269~275 (1999)
- Morgan T, "The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor(perindopril)administered in the morning or at night", J Hypertens, 15, pp.205~211 (1997)
- Palatini P, "Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24hours?", Am Heart J, 123, pp.1421~1425 (1992)
- Palatini P, "Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril", Clin Pharmacol Ther, 52, pp.378~383 (1992)
- Zaslavskaia RM, "Time-dependent effects of ramipril in patients with hypertension of 2 stage", Klin Med(Mosk), 77, pp.41~44 (1999)
- Kuroda T, "Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients", Hypertens Res, 27, pp.15~20 (2004)
- Ohmori M, "ACE inhibitors and chronotherapy", Clin Exp Hypertens, 27, pp.179~185 (2005)
- Hermida RC, "Chronotherapy of hypertension : administration-time-dependent effects of treatment on the circadian pattern of blood pressure", Adv Drug Deliv Rev, 59, pp.923~939 (2007)
- Hermida RC, "Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial", Eur Heart J, 41, pp.4565~4576 (2020)
- Park J, "Effect of night shift work on the control of hypertension and diabetes in workers taking medication", Ann Occup Environ Med, 31, pp.e27~ (2019)
- Chau NP, "Twenty-fourhour ambulatory blood pressure in shift workers", Circulation, 80, pp.341~347 (1989)
- Morris CJ, "Circadian misalignment increases cardiovascular disease risk factors in humans", Proc Natl Acad Sci U S A, 113, pp.E1402~E1411 (2016)
- Zhao P, "Evening versus morning dosing regimen drug therapy for hypertension", Cochrane Database Syst Rev, 2011, pp.CD004184~ (2011)
- Brunström M, "Missing verification of source data in hypertension research : the HYGIA PROJECT in perspective", Hypertension, 78, pp.555~558 (2021)
- Mackenzie IS, "Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial", Lancet, 400, pp.1417~1425 (2022)
- Garrison SR, "Bedtime versus morning use of antihypertensives for cardiovascular risk reduction(BedMed) : protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial", BMJ Open, 12, pp.e059711~ (2022)
- "BedMed-Frail: does the potential benefit of bedtime antihypertensive prescribing extend to frail populations?" (2023)[URL]
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Williams B, "2018 ESC", ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension, 2018, pp.36, 1953~2041
- Kim HL, "The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension", Clin Hypertens, 29, pp.11~ (2023)
- ElSayed NA, "10. Cardiovascular disease and risk management : standards of care in diabetes-2023", Diabetes Care, 46(Suppl 1), pp.S158~S190 (2023)
- Umemura S, "The Japanese Society of Hypertension Guidelines for the Management of Hypertension(JSH 2019)", Hypertens Res, 42, pp.1235~1481 (2019)
- Pierdomenico SD, "Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease", J Am Coll Cardiol, 31, pp.1627~1634 (1998)
- Kario K, "Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives", Hypertension, 38, pp.852~857 (2001)
